NX PharmaGen Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Employees
  • 3
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $486K
Latest Deal Amount
  • Investors
  • 4

NX PharmaGen General Information

Description

Developer of molecular diagnostics and tumor imaging platform designed to diagnose preterm birth, cancer, and other diseases. The company's platform uses proteomics to collect valuable diagnostic data and other biomarker signatures associated with prenatal and oncology conditions via the analysis of biomarker-containing microvesicles shed from a placental, tumor, or diseased cells into the bloodstream, enabling medical practitioners to get actionable and disease-specific molecular data in a repeatable and cost-effective manner.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Monitoring Equipment
Other Healthcare Technology Systems
Primary Office
  • 4350 Brownsboro Road
  • Suite 110
  • Louisville, KY 40207
  • United States
+1 (502) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NX PharmaGen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 18-Aug-2020 $486K 00.000 Completed Generating Revenue
3. Early Stage VC 25-Jun-2013 00000 00.000 Completed Generating Revenue
2. Early Stage VC 01-Jan-2012 $3.5M $3.5M Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view NX PharmaGen’s complete valuation and funding history, request access »

NX PharmaGen Executive Team (2)

Name Title Board Seat Contact Info
Brian Brohman Co-Founder, Co-Chief Executive Officer, Chief Business Officer and Board Member
Alan Ezrin Ph.D Co-Founder, Co-Chief Executive Officer & Board Member
To view NX PharmaGen’s complete executive team members history, request access »

NX PharmaGen Board Members (7)

Name Representing Role Since
Alan Ezrin Ph.D Self Co-Founder, Co-Chief Executive Officer & Board Member 000 0000
Brian Brohman NX PharmaGen Co-Founder, Co-Chief Executive Officer, Chief Business Officer and Board Member 000 0000
Cedric Francois Ph.D Self Board Member & Advisor 000 0000
Fred Mermelstein Ph.D Self Board Member & Advisor 000 0000
Pascal Deschatelets Ph.D Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

NX PharmaGen Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NX PharmaGen Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Mammoth View (KSTC) Venture Capital Minority 000 0000 000000 0
US Angel Investors Angel Group Minority 000 0000 000000 0
VisionTech Partners Angel Group Minority 000 0000 000000 0
XLerateHealth Accelerator/Incubator Minority 000 0000 000000 0
To view NX PharmaGen’s complete investors history, request access »

NX PharmaGen Subsidiaries (1)

Company Name Industry Location Founded
00 00000000 Decision/Risk Analysis Louisville, KY 0000
To view NX PharmaGen’s complete subsidiaries history, request access »